Subscription Required

Only paid subscribers* to Drug Benefit News can access this Web portal with three years of back issues, searchable article archives and other valuable resources.

Subscribers to Drug Benefit News receive

  • 24 biweekly issues of timely news and insightful strategies for reducing costs and improving outcomes, delivered by First Class U.S. Mail and electronically,
  • E-News Alerts whenever important news breaks, and
  • Access to a subscriber-only Web page with:
    • Searchable archives of past articles,
    • Convenient library with PDFs of back issues,
    • Recent stories of interest and hot topic articles grouped for convenient reading, and
    • Regular postings from your editor.
View a sample and get more information
May 22, 2015

Recent Stories of Interest

From Drug Benefit News - Before UnitedHealth Group and Catamaran Corp. on March 30 unveiled plans to combine the stand-alone PBM with the health plan operator’s OptumRx unit (DBN 4/3/15, p. 1), the PBM contemplated multiple transaction options, according to a new proxy statement filed by Catamaran. These include potential combinations with several unnamed parties, such as one that analysts believe to be Express Scripts Holding Co., which could have raised significant antitrust concerns. Read more

At a time when many commercial and Medicare plans are tweaking and… Read more

As the big three publicly traded PBMs reported first-quarter 2015 earnings, there… Read more

Despite Otsuka Pharmaceutical Co., Ltd.’s best efforts to block any generic version… Read more

From the Editor

Welcome to your Drug Benefit News subscriber-only Web page

Be sure to visit often, for PDFs of issues, archives of articles and data, and more!

Please e-mail me with comments on the last issue of Drug Benefit News, story ideas for future issues or any other suggestions you have that can make the newsletter more useful for you.

May 21, 2015
CVS Agrees to Acquire Omnicare

CVS Health plans to buy LTC pharmacy services provider Omnicare in a deal worth $12.7 billion.

April 21, 2015
Compounded Drugs Drove Employee Costs in 2014

Compounded medicine once again drove workers' compensation drug costs in 2014, says new Express Scripts report.

April 16, 2015
FDA Approves First Generic Copaxone for MS

The FDA approved Sandoz’s Glatopa, the first generic version of Teva’s multiple sclerosis treatment Copaxone (glatiramer acetate) in a 20 mg/ml once-daily injection

Updated Regularly

Featured Hot Topics

Search for your own Hot Topics

It's quick and easy to sign up for FREE access to!

Why do I need to register?